USE OF HIGH POTENCY STATINS FOR PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: PRACTICE IMPACT OF THE NEW CHOLESTEROL GUIDELINES

被引：0
|
作者：
Rodriguez, Fatima [1 ]
Heidenreich, Paul [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)61436-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1178-104
引用
收藏
页码：A1436 / A1436
页数：1
相关论文
共 50 条
  • [21] Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease
    Xiao, Zhiwen
    Lin, Zhongqiu
    Xu, Lin
    Xu, Wenlong
    Huang, Haoxiang
    Wang, Yuegang
    Cao, Shiping
    Xie, Zhiquan
    Liao, Wangjun
    Liao, Yulin
    Bin, Jianping
    Feng, Weijing
    Chen, Yanmei
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (17) : 1924 - 1934
  • [22] Lipid management in patients with atherosclerotic cardiovascular disease: it is time to apply the guidelines!
    Hauguel-Moreau, Marie
    Kavousi, Maryam
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (15) : 1790 - 1791
  • [23] Clinical use of statins and cholesterol goals in patients with several cardiovascular risk factors
    Gómez-Belda, A
    Rodilla, E
    Albert, A
    García, L
    González, C
    Pascual, JM
    MEDICINA CLINICA, 2003, 121 (14): : 527 - 531
  • [24] REMNANT CHOLESTEROL IN PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CORONARY ARTERY DISEASE. OUR EXPERIENCES
    Burazor, I.
    Otasevic, P.
    Tasic, N.
    Jakovljevic, V.
    Bojic, M.
    ATHEROSCLEROSIS, 2023, 379 : S180 - S180
  • [25] Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins
    Vijayaraghavan, K.
    Baum, S.
    Desai, N. R.
    Voyce, S. J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [26] The Impact of Practice Facilitation on Adherence to Cardiovascular Disease Prevention Guidelines
    Siman, Nina
    Cleland, Charles
    Berry, Carolyn
    Cuthel, Allison
    Gepts, Thomas
    Shelley, Donna
    CIRCULATION, 2018, 138
  • [27] Is cholesterol lowering with statins the gold standard for treating patients with cardiovascular risk and disease?
    Sinatra, ST
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (03) : 220 - 222
  • [28] Is cholesterol lowering with statins the gold standard for treating patients with cardiovascular risk and disease?
    Stricker, RB
    Goldberg, B
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (08) : 837 - 837
  • [29] Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease
    Bao-tao Huang
    Yong Peng
    Fang-yang Huang
    Tian-li Xia
    Yi-yue Gui
    Yan-biao Liao
    Xiao-bo Pu
    Shi-jian Chen
    Yong Yang
    Mao Chen
    Internal and Emergency Medicine, 2017, 12 : 1121 - 1129
  • [30] PATIENTS' AND HEALTHCARE PROFESSIONALS' PREFERENCES REGARDING LIPID-LOWERING THERAPIES FOR PATIENTS WITH VERY HIGH CARDIOVASCULAR RISK AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Garcia, Parrondo F. J.
    Olmo, Fernandez M. R.
    Hermida, Alvarez A. B.
    Castellanos, M.
    Gomez, Cerezo J.
    Guaita, Igual M. J.
    Chaparro, Jansen S. J.
    Rebollar, Obaya J. C.
    Mitjana, Martin L.
    Cosin-Sales, J.
    VALUE IN HEALTH, 2023, 26 (12) : S448 - S448
12345